Company profile: Ablacon
1.1 - Company Overview
Company description
- Provider of AI-guided atrial fibrillation therapies, including the Ablamap System to localize and characterize functional mechanisms of AF for customized ablation; the Ablacath Mapping Catheter, used with Ablamap to identify and ablate sources outside the pulmonary veins; and the EGF Mapping System using electrographic flow mapping to detect and quantify patterns of electrical wavefront propagation in the atria.
Products and services
- Ablamap System: AI-guided mapping platform that delivers advanced algorithmic localization and characterization of atrial fibrillation mechanisms, enabling physicians to tailor ablation strategies with targeted specificity
- EGF Mapping System: Electrographic-flow mapping apparatus that produces detection and quantification of electrical wavefront propagation patterns in the atria, aiding identification of atrial fibrillation sources
- Ablacath Mapping Catheter: Catheter-based component that integrates with the Ablamap System to identify and ablate atrial fibrillation sources outside the pulmonary veins, offering targeted extra-pulmonary ablation guidance
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ablacon
Morphogen-IX
HQ: United Kingdom
Website
- Description: Provider of drug discovery developing bone morphogenetic proteins as a novel therapy for pulmonary arterial hypertension, a severe, life-limiting disease affecting lung blood vessels and leading to heart failure; founded in 2015 by Index Ventures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Morphogen-IX company profile →
Cardiac Dimensions
HQ: United States
Website
- Description: Provider of tools and techniques for the treatment of heart failure and related conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiac Dimensions company profile →
Verathon
HQ: United States
Website
- Description: Provider of medical devices and services, designing, manufacturing and distributing solutions for airway management and bladder volume measurement, including GlideScope video laryngoscopes, GlideScope Core airway visualization systems, GlideScope Go 2 for EMS, GlideScope Spectrum QC single-use laryngoscopes, BFlex single-use bronchoscopes, and BladderScan ultrasound devices with AI.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verathon company profile →
Adona Medical
HQ: United States
Website
- Description: Provider of heart failure management systems, including the Adona Interatrial Shunt with integrated bi-atrial pressure monitoring enabling individualized shunting; bi-atrial pressure sensors delivering direct LA and RA readings with >5 automated readings/day; shape memory Nitinol shunt lumen adjustment technology; and the Adona Induction Catheter for non-contact inductive energy transfer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adona Medical company profile →
Arbor Surgical
HQ: United States
Website
- Description: Provider of cardiovascular medical device technologies focused on the heart valve replacement market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arbor Surgical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ablacon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ablacon
2.2 - Growth funds investing in similar companies to Ablacon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ablacon
4.2 - Public trading comparable groups for Ablacon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →